Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

What Predicts Long-Term Survival After Heart Transplantation

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

Benny Weksler, MD, Jennifer L. Sullivan, MD

Triple Bridge to Simultaneous Heart and Kidney Transplantation

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Implantation of HeartMate II Left Ventricular Assist Device in a Single-Lung Patient Hannah Copeland, MD, Liset Stoletniy, MD, Antoine Sakr, MD, Anees.

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Dhaval Chauhan, MD, Alexis K

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy Chang Hyun Kang, MD, PhD, Yoohwa Hwang,

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Who Do You Say You Are? The Annals of Thoracic Surgery

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Ventricular assist device programs: design and function

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Left Ventricular Assist Device Destination Therapy Versus Extended Criteria Cardiac Transplant Mani A. Daneshmand, MD, Keshava Rajagopal, MD, PhD, Brian.

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry Jens Garbade, MD, PhD, Finn Gustafsson,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Dhaval Chauhan, MD, Alexis K

Editorial Board, January 2010

William M. Whited, MD, Paul Henley, BS, Erin M

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

An Unusual Cause of Hemoptysis in a Young Woman

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Invited Commentary The Annals of Thoracic Surgery

Robert Lee Replogle, September 30, 1931–May 9, 2016

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

The American Board of Thoracic Surgery: Update

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Iki Adachi, MD, Muhammad S. Khan, MD, Francisco A

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

William T. Brinkman, MD, Morley A. Herbert, PhD, Syma L

Costs Associated With Ventricular Assist Device Use in Children

Jonathan P. Martin, BA, Jeremiah G. Allen, MD, Eric S

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Heart Transplant Program Volume Is Not a Measure of Quality

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Ramesh Singh, MD, Matthew L. Williams, MD, Mark S. Slaughter, MD The Annals of Thoracic Surgery Volume 98, Issue 3, Pages 830-834 (September 2014) DOI: 10.1016/j.athoracsur.2014.05.019 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Survival between HeartMate II (HM II) and non–left ventricular assist device (LVAD) groups in unmatched cohort. The Annals of Thoracic Surgery 2014 98, 830-834DOI: (10.1016/j.athoracsur.2014.05.019) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Distribution of newly listed patients in HeartMate II (HM II) and non– left ventricular assist device (LVAD) groups by listing year. (MCS = mechanical circulatory support.) The Annals of Thoracic Surgery 2014 98, 830-834DOI: (10.1016/j.athoracsur.2014.05.019) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Annual mortality rate on waiting list by listing year. The Annals of Thoracic Surgery 2014 98, 830-834DOI: (10.1016/j.athoracsur.2014.05.019) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival between HeartMate II (HM II) and non–left ventricular assist device (LVAD) groups in propensity-matched cohort. The Annals of Thoracic Surgery 2014 98, 830-834DOI: (10.1016/j.athoracsur.2014.05.019) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions